Applied Molecular Evolution, Inc. (AME) (AMEV) Announces Positive Rulings In Kauffman Patent Litigation
10/19/2005 5:12:36 PM
More...
|
Applied Molecular Evolution (AMEV) Files Investigational New Drug Application For AME-527, Next-Generation Remicade(R), In Rheumatoid Arthritis
10/19/2005 5:10:47 PM
More...
|
Applied Molecular Evolution (AMEV) To Present At CIBC World Markets Healthcare Conference November 10
10/19/2005 5:10:22 PM
More...
|
Applied Molecular Evolution (AMEV) Reports Financial Results For Third Quarter 2003
10/19/2005 5:10:16 PM
More...
|
Eli Lilly and Company (LLY) Completes Acquisition Of Applied Molecular Evolution (AMEV)
10/19/2005 5:10:01 PM
More...
|
Applied Molecular Evolution (AMEV) Stockholders Approve Acquisition By Eli Lilly and Company (LLY)
10/19/2005 5:09:59 PM
More...
|
Applied Molecular Evolution (AMEV) Announces Early Termination Of Hart-Scott-Rodino Waiting Period For Proposed Merger With Eli Lilly and Company (LLY)
10/19/2005 5:09:40 PM
More...
|
Applied Molecular Evolution (AMEV) Sets January 5, 2004 As Record Date For Stockholder Meeting To Vote On Proposed Merger
10/19/2005 5:09:36 PM
More...
|
Eli Lilly and Company, (LLY) Applied Molecular Evolution (AMEV) Deal Has $20.25 Million Breakup Fee
10/19/2005 5:09:34 PM
More...
|
Eli Lilly and Company (LLY) And Applied Molecular Evolution (AMEV) Evolution Announce Merger Agreement
10/19/2005 5:09:15 PM
More...
|